Baricitinib Related Compounds & Impurities

Baricitinib is a selective JAK1/JAK2 inhibitor used for rheumatoid arthritis, alopecia areata and, under specific authorisations.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Baricitinib reference standards, pharmacopeial and non-pharmacopeial Baricitinib impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Baricitinib-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Baricitinib
(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)methanol
Baricitinib Diamine Impurity
Ruxolitinib Hydroxy Impurity
Baricitinib Sulfonyl Impurity
Baricitinib impurity A
Baricitinib impurity C
Baricitinib Impurity 6
Baricitinib Impurity IV
Baricitinib Impurity VII
Baricitinib Impurity 7
Acetamide Baricitinib Impurity
Baricitinib Acetic Acid Impurity
Baricitinib Impurity VIII
Baricitinib Impurity V
Barcitinib Lactone Impurity
4-bromopyrazole
6-Amino-5-(2,2-diethoxyethyl)-2-mercaptopyrimidin-4-ol
6-Amino-5-(2,2-diethoxyethyl)-4-hydroxypyrimidine
Baricitinib Nitroso Impurity
Baricitinib Impurity 23
3-Azetidinylidene acetonitrile
Baricitinib Impurity III
Baricitinib Impurity 29
Baricitinib Impurity 28
Baricitinib Impurity 30
Baricitinib Impurity 16
Baricitinib Impurity 17
Baricitinib Impurity 32
Baricitinib Impurity 25
Baricitinib Impurity 37
Baricitinib Impurity 36
Baricitinib Impurity 38
Baricitinib Impurity 4
Baricitinib Impurity 5
Baricitinib Impurity 8
Baricitinib Impurity 9
Baricitinib Impurity 10
Baricitinib Impurity 11
Baricitinib Impurity 12
Baricitinib Impurity 13
Baricitinib Impurity 15
Baricitinib Impurity 18

Isotope Labelled Compounds

Baricitinib D5